Search the Newsreel

Humana’s Q2 Earnings Beat on Cash Flow. Margins Told a Different Story.

What Humana (HUM)'s Q2 Beat, EPS Cut and Buybacks Mean For Shareholders

Human Xtensions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026

Is Humana (HUM) an Undervalued Turnaround Play as Medicare Margins Recover?

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Large Cap Strategy". A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index's 13.87% …

Janus Henderson Group PLC Raises Stock Holdings in Humana Inc. $HUM

Janus Henderson Group PLC increased its stake in Humana Inc. by 8.8% in the first quarter, now holding 219,065 shares valued at $38.0 million. This comes as Humana reported strong second-quarter results, exceeding revenue and adjusted EPS expectations, although its unchanged full-year guidance and …

Humana Inc. (NYSE:HUM) Given Consensus Recommendation of "Hold" by Brokerages

Humana Inc. (NYSE:HUM) has received a consensus "Hold" recommendation from 30 brokerages, with an average 12-month price target of $386.61. Despite exceeding second-quarter earnings expectations with adjusted EPS of $7.61 and revenue of $40.89 billion, the company's decision to maintain full-year guidance and exit …

Humacyte, Inc. Revenue Breakdown – NASDAQ:HUMA

Humacyte, Inc. (NASDAQ: HUMA) generated $2.04 million USD in revenue last year, primarily from its Acellular Human Tissues segment. This represents an increase from $1.56 million USD in the previous year, with the United States being the sole contributor to this revenue.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by Humana Inc. (HUM). The firm is encouraging investors who purchased Humana securities prior to June 27, 2022, and still hold them, to come forward and assist with the investigation. The …

Amundi Purchases 37,501 Shares of Humana Inc. $HUM

Amundi increased its stake in Humana Inc. by 9.0% in Q1, purchasing an additional 37,501 shares to own a total of 455,385 shares valued at $78.96 million. Other institutional investors also adjusted their holdings. Humana's stock performance saw mixed sentiment with analyst upgrades and …

HUM Q2 Deep Dive: Margin Initiatives, Operational Progress, and Medicare Advantage Strategy

HUM Q2 Deep Dive: Margin Initiatives, Operational Progress, and Medicare Advantage Strategy Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.89 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts' …

Humana Elects Paul Smith and Frederick Crawford to Board of Directors

Humana Inc. has announced the election of Paul Smith and Frederick Crawford to its Board of Directors, effective immediately. Smith, Chief Commercial Officer at Anthropic PBC, brings over 30 years of experience in enterprise technology and scaling go-to-market strategies. Crawford, former President and COO …

US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Humana Inc. said Wednesday it plans to exit additional Medicare Advantage plans in 2027, a move expected to affect about 600,000 members. The insurer said the changes …

Humacyte Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Humacyte (HUMA) has received a notice from Nasdaq stating that its common stock failed to meet the minimum $1.00 bid price requirement for 30 consecutive business days. The company has until January 27, 2027, to regain compliance by maintaining a closing bid price of …

Humana (HUM) Adds Anthropic And Aflac Veterans To Its Board

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Humana has elected Paul Smith, Chief Commercial Officer at AI firm Anthropic, to its Board of Directors. The company has also elected Frederick …

Medicare Advantage Insurers Are Redrawing the Map for 2027. Members Find Out by Letter This Fall.

Quick Read UnitedHealth (UNH) trims 1.1 million MA members as Humana (HUM) targets 25% growth, with both strategies already locked into 2027 benefit letters. Members whose plan exits have a 63-day guaranteed-issue Medigap window; miss it and insurers can medically underwrite, charge more, or …

Humana Targets ’27 Plan Exits Affecting About 600,000 People

Humana plans to shed approximately 600,000 members in 2027 by exiting certain markets and concentrating on higher-profitability insurance plans, many of which utilize value-based care. This strategic move aims to improve the company's margins, even as it faces rising treatment and drug costs. CEO …

SummitTX Capital L.P. Invests $834,000 in Humana Inc. $HUM

SummitTX Capital L.P. recently acquired a new position in Humana Inc. (NYSE:HUM) valued at approximately $834,000. Several other institutional investors also adjusted their holdings in Humana, with 92.38% of the stock owned by institutional investors. The article details Humana's recent earnings, price performance, and …

Kentucky Retirement Systems Increases Stock Position in Humana Inc. $HUM

Kentucky Retirement Systems significantly increased its stake in Humana Inc. by 69.8% in the first quarter of 2026, bringing its total holdings to 12,872 shares valued at approximately $2.23 million. This move comes as Humana exceeded second-quarter revenue and adjusted EPS expectations, although its …

Humana (HUM) Stock Stays Calm As Margin Repair Starts To Show

Ihuman Inc (IH) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Ihuman Inc (IH), highlighting its current valuation score of 7.41 and its P/E ratio of 5.24. It notes that the company ranks 335 out of 486 in the Software & IT Services industry, with its P/E ratio …

Piper Sandler upgrades Humana stock rating on margin recovery outlook

Piper Sandler has upgraded Humana Inc. (NYSE:HUM) to Overweight from Neutral, raising its price target to $463 due to an expected improvement in Individual Medicare Advantage margins and strong enterprise earnings growth. The firm anticipates margins to recover to 2.5% by calendar year 2028 …

Humana (HUM) Stock Trades Down, Here Is Why

Humana (HUM) Stock Trades Down, Here Is Why What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 7.2% in the afternoon session after the company reported a solid second-quarter earnings beat but was overshadowed by a concerning outlook for future profitability. The company …

Guggenheim raises Humana stock price target on margin outlook

Guggenheim has increased its price target for Humana Inc. (NYSE:HUM) to $471 from $269, maintaining a Buy rating, based on the health insurer's focus on Medicare Advantage margin expansion. Despite a recent stock dip after Q2 2026 results, Guggenheim projects significant annual margin recovery …

This Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

This article details the top five stock downgrades by Wall Street analysts on Thursday. Notably, a Raymond James analyst downgraded Humana (NYSE: HUM) from Outperform to Market Perform. Other companies experiencing downgrades include Paymentus Holdings Inc (NYSE: PAY), Masco Corp (NYSE: MAS), Fiverr International …

Humana plans to exit some MA markets next year, affecting 600,000 members

Humana announced plans to exit some of its less profitable Medicare Advantage markets in 2027, which is expected to affect approximately 600,000 members. The company's primary goal is to achieve a sustainable margin of at least 3%. Despite these exits, Humana reported significant individual …

Humana Medicare Advantage Cuts: What are the recent changes made in your plan that you must know?

Humana is adjusting its Medicare Advantage plans for 2027, discontinuing some in certain markets due to rising medical costs and changes in federal reimbursement. While not all enrollees will be affected, members are advised to review their Annual Notice of Change (ANOC) and consider …

Ihuman Inc (IH) Financial Health: Profitability & Balance Sheet Analysis

Ihuman Inc (IH) has a robust financial status despite its low operating efficiency, with a current financial score of 6.75, ranking 300 out of 485 in the Software & IT Services industry. The company's latest quarterly revenue decreased by 8.51% year-over-year to $26.86M, and …

Humacyte Inc (HUMA) Institutional Confidence

Humacyte Inc (HUMA) has an institutional shareholding score of 3.00, placing it 191st out of 384 in the Biotechnology & Medical Research industry. Institutional investors currently hold 32.47% of shares, a 29.83% increase quarter-over-quarter. While some institutions like Fresenius SE & Co KGaA hold …

Humana Q2 Earnings Call Highlights

Humana's Q2 earnings call highlighted that the company is on track for its 2026 performance goals, emphasizing planned Medicare Advantage margin expansion by 2027 and aiming for a 3% pretax margin by 2028. The company is strategically exiting certain plans and focusing on efficiency …

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC is investigating whether certain officers and directors of Humana Inc. breached their fiduciary duties to shareholders. The firm is encouraging long-term Humana shareholders to contact them to discuss their legal rights and options, which could include corporate governance reforms or financial …

Ensign Group, Humana, Vitas Healthcare, Option Care Health report second-quarter earnings

The Ensign Group, Humana, Vitas Healthcare, and Option Care Health recently reported their second-quarter earnings. Ensign Group saw strong demand and anticipates a busy acquisition period, planning to expand into new states and having acquired 71 assets since 2025. Humana reaffirmed its commitment to …

Humana Inc. Q2 2026 Earnings Call Summary

Humana Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track (NYSE:HUM)

Humana Inc. reported Q2 2026 earnings, reiterating its goal of achieving a sustainable 3% pre-tax margin by 2028 through improved Medicare Advantage plan quality and operational efficiency. Despite strong revenue growth, profit margins have seen a significant decline, with Q2 2026 pre-tax margin at …

Humana Inc (HUM) Q2 2026 Earnings Call Highlights: Strategic Exits and Margin Expansion Plans

This article first appeared on GuruFocus. Operating Cost Ratio: Down 120 basis points year over year in Q2. Full-Year Operating Cost Reduction Expectation: Approximately 150 basis points. 2026 Cost Trend: High single-digit range, 7% to 8%, inclusive of medical and pharmacy. Individual MA Pretax …

Humana Inc Q2 2026: Revenue $40.9B, EPS $5.73— 10-Q Summary

Humana Inc. reported strong second-quarter 2026 results, with revenue reaching $40.9 billion and diluted EPS of $5.73. This represents double-digit year-over-year growth in both revenue (26.2%) and net income (27.6%), driven primarily by expansion in Medicare membership and higher per-member premiums. The company also …

[10-Q] HUMANA INC Quarterly Earnings Report

Humana Inc. (HUM) filed its unaudited quarterly report Form 10-Q for the period ended June 30, 2026. The report details $1.32 billion of commercial paper outstanding, $5.0 billion in revolving borrowing capacity, and the completed acquisition of MaxHealth for approximately $908 million. The company …